Production of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived Cells - sprookjes - yvandenbroek - TriplyDB

Production of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived Cells

Production of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived Cells

http://www.wikidata.org/entity/Q27477544

about

Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus and Host A virocidal amphipathic -helical peptide that inhibits hepatitis C virus infection in vitro Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes Three-dimensional Huh7 cell culture system for the study of Hepatitis C virus infection Hepatitis C Virus Infection in Phenotypically Distinct Huh7 Cell Lines Development of a Cell-Based Hepatitis C Virus Infection Fluorescent Resonance Energy Transfer Assay for High-Throughput Antiviral Compound Screening Cellular growth kinetics distinguish a cyclophilin inhibitor from an HSP90 inhibitor as a selective inhibitor of hepatitis C virus Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents Real-time monitoring of metabolic function in liver-on-chip microdevices tracks the dynamics of mitochondrial dysfunction Rapid intracellular competition between hepatitis C viral genomes as a result of mitosis.The hepatitis C virus NS5A inhibitor daclatasvir has a dual mode of action and leads to a new virus half-life estimate Hepatitis C virus experimental model systems and antiviral drug research.Viral kinetics suggests a reconciliation of the disparate observations of the modulation of claudin-1 expression on cells exposed to hepatitis C virus.Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes.Identification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assay Potential treatment options and future research to increase hepatitis C virus treatment response rate Hepatitis C viral entry inhibitors prolong viral suppression by replication inhibitors in persistently-infected Huh7 cultures Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma.New Methods in Tissue Engineering: Improved Models for Viral Infection Quantification of Hepatitis C Virus Cell-to-Cell Spread Using a Stochastic Modeling Approach.Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.RNA-sequencing analysis of 5' capped RNAs identifies many new differentially expressed genes in acute hepatitis C virus infection Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C Virus.Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.Identification of transferrin receptor 1 as a hepatitis C virus entry factor Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators.Hepatitis c virus genotype 4 replication in the hepatocellular carcinoma cell line HepG2/C3A.Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.Evaluation of CYP3A4 inhibition and hepatotoxicity using DMSO-treated human hepatoma HuH-7 cells.Scotomas in molecular virology and epidemiology of hepatitis C virus.Cellular and molecular biology of HCV infection and hepatitis.Determining the involvement and therapeutic implications of host cellular factors in hepatitis C virus cell-to-cell spread Advances and challenges in studying hepatitis C virus in its native environment.Experimental models for predicting drug absorption and metabolism.Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virus.Optimizing human hepatocyte models for metabolic phenotype and function: effects of treatment with dimethyl sulfoxide (DMSO).Stable Overexpression of the Constitutive Androstane Receptor Reduces the Requirement for Culture with Dimethyl Sulfoxide for High Drug Metabolism in HepaRG Cells.A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene.Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro.A small-molecule inhibitor of hepatitis C virus infectivity.

P2860

Q27477623-C8879F46-9814-4F76-810E-823059137306 Q27485575-B2FF37BB-82CB-474E-BC7D-D54630D3A30C Q27487541-53B0A647-091B-4DB6-82E6-59A243FD4DD6 Q27489062-6F1D471E-7AAE-4786-966C-104360AEBE70 Q27489071-E2C154A6-B36F-4E4B-AC8E-F0DAA5A3A941 Q27490187-D6703596-B996-4276-AAFC-BE252ACC38A3 Q28480556-42B5CAB3-91C3-45BD-9C9E-D96D1991E330 Q28538891-42180209-3EEE-4D1F-A8DD-6D3E922434CE Q28834338-9D1F7F63-9F9E-4834-9316-25D79063AE92 Q30531290-21DAA100-6E05-4054-B6AB-A5CB9323FC2A Q33794371-E70ABA18-8B64-4C9D-B5F4-F274A9E3802B Q34235286-7AAF2AB5-85DC-4D2C-982B-ADB162618142 Q34251341-14B5302D-9FE2-4572-87D2-C6CAA3EC56E5 Q34258650-CCE79E1B-3E3E-4362-9601-CF06D003145C Q34403294-93EDB383-0AE8-430D-AEC8-A71EB9A5D87E Q34576190-19AAE9F1-1DB7-49D6-BF45-257C0709BC8A Q34766299-D8E0BA91-797C-4BED-A9A1-A0C986374DB9 Q35083883-247E07F7-0BC3-444F-B73D-50E1A30CCA2A Q35431256-A854B009-D35F-4C5E-A41C-75C39E488AB8 Q35745457-FB4E29F8-3EB1-4FE6-9801-0B3C8C753F01 Q35839680-8BB740EA-3CE1-43A7-A7A8-2B20F18519DA Q35943663-23EB5527-16B1-4865-A3DE-BAA5CC9015F8 Q35975438-5520F072-41A2-432A-AEB1-E96211995235 Q36760026-FAECF16F-25FC-4A4A-B02F-75CD4CDA0B6D Q36967731-4E135536-0463-4637-AB3A-C7F0C72303C2 Q36968841-B51A4D73-1706-4759-BA50-8EF5A965E474 Q36981344-B1DD26AB-ED5C-4B9D-853D-25BDA9357807 Q37073281-EACABFC2-3984-4787-A507-41A0D02D728E Q37145683-3AF85A18-661B-4BE1-A16F-19FCD3AE746D Q37358620-2FDD8AE1-5CAA-493F-A269-8D9E241EBEAC Q37514366-6833826E-FB65-4C62-891B-C89A1D456794 Q37713961-E3521E1E-755A-4E9A-88EA-4B7522A2EC20 Q37798816-94898BB7-CC3C-4D64-BF5E-D7E453B63A37 Q38107970-F88AD19B-71E5-4BEE-984E-A0047F0A65C0 Q38637134-4548E1D0-570E-4A52-9DA8-E5FD03459BEF Q38734208-8AA70BF0-D534-467E-8151-ED9017F50611 Q38736787-F401C32D-951B-4F89-8302-860A854733D0 Q38848401-1DAEDB6B-C551-4223-A20F-0DDB531EF9E7 Q38881833-B5A2E174-04CD-4410-8720-BA537311C9AB Q39069509-014B46FD-3B8D-4B12-97E6-7E0641BA3B5E

P2860

Production of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived Cells

http://www.wikidata.org/entity/Q27477544

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Production of Infectious Hepat ...... d Human Hepatoma-Derived Cells

@ast

Production of Infectious Hepat ...... d Human Hepatoma-Derived Cells

@en

Production of Infectious Hepat ...... d Human Hepatoma-Derived Cells

@nl

type

label

Production of Infectious Hepat ...... d Human Hepatoma-Derived Cells

@ast

Production of Infectious Hepat ...... d Human Hepatoma-Derived Cells

@en

Production of Infectious Hepat ...... d Human Hepatoma-Derived Cells

@nl

prefLabel

Production of Infectious Hepat ...... d Human Hepatoma-Derived Cells

@ast

Production of Infectious Hepat ...... d Human Hepatoma-Derived Cells

@en

Production of Infectious Hepat ...... d Human Hepatoma-Derived Cells

@nl

P1433

Q27477544-F97CFB18-8062-4C4A-B401-5BF724812600

P1476

Q27477544-3A3E8F37-7A2F-4507-9F40-BE9C14819AE1

P2093

Q27477544-D3F8649D-4ABA-4FE6-8AB0-7CA21190DA73

P2860

Q27477544-0A1D08F6-E24C-45AF-ABA7-0372363A546E

Q27477544-148BB49C-65E6-463D-A92F-C5CDD443A1C9

Q27477544-188844C4-65FB-4BEA-A9B2-4850F953A836

Q27477544-1A381F6C-2809-4075-875E-AD0F03A79174

Q27477544-1E32C032-A310-4B26-9AD5-73DC58CFABAD

Q27477544-346BD68D-756C-4F51-9AF5-56947A797B68

Q27477544-350BFE98-960E-4D58-A8AC-622DE75691C5

Q27477544-35642DD3-D268-479C-B9B4-D0BCD978BC79

Q27477544-384AF849-8007-4FB4-A4F7-B05A0035D014

Q27477544-3ACAB707-8F46-41DB-AD59-5585AC32DDA8

P304

Q27477544-D849F1B4-72CF-4995-95D1-788E9A50093E

P31

Q27477544-BB8F8969-60A0-4C68-B1A3-16652C2E5C68

P3181

Q27477544-675549F3-14C8-40C1-887D-09BDAE8B363E

P356

Q27477544-BE138A1F-3980-4B57-B9F1-CEFB435E5227

P433

Q27477544-FE80A2C9-1FE1-4725-8D17-B97227D83E9A

P478

Q27477544-99C5755C-27D2-4468-B539-1687C3DF9880

P50

Q27477544-54C1CE6C-7C38-4C94-B441-6D2F6F71A076

P577

Q27477544-02CF5120-97E7-439E-86A0-3398CB45ECF1

P698

Q27477544-94F69766-D0DB-4000-84D3-1EB76A74D76A

P921

Q27477544-87765207-C960-45AC-83E9-CAE02DCAACAF

P932

Q27477544-A97FCC59-04CC-426C-967A-C8F9D3DCD925

P3181

P356

P1433

Journal of Virology

P1476

Production of Infectious Hepat ...... d Human Hepatoma-Derived Cells

@en

P2093

Bruno Sainz

http://www.w3.org/2001/XMLSchema#string

P2860

Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb

Multistable and multistep dynamics in neutrophil differentiation.

Characterization of cell lines carrying self-replicating hepatitis C virus RNAs.

Robust hepatitis C virus infection in vitro.

Stealth and cunning: hepatitis B and hepatitis C viruses.

Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line

Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression

Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.

Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection

Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.

P304

10253-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1943717

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.01059-06

http://www.w3.org/2001/XMLSchema#string

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

Francis V. Chisari

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17005703

http://www.w3.org/2001/XMLSchema#string

P921

P932

1617281

http://www.w3.org/2001/XMLSchema#string